Abstract
Rationale
Insomnia is a common and disabling complaint for which there is a need for improved treatments. Successful drug discovery relies on the use of appropriate animal models to assess likely outcome in the clinic.
Objectives
The purpose of this study was to develop a translational, caffeine-induced model of insomnia in rats and healthy volunteers. We used sleep onset latency (SOL) as a comparable sleep measure between the two species. The model was validated by two effective sleep-promoting agents with different pharmacology, zolpidem and trazodone, which have GABA-ergic and serotonergic mechanisms, respectively.
Materials and methods
In rats, radiotelemetry transmitters with electroencephalogram and electromyogram electrodes were implanted for sleep recording. Animals were administered with caffeine alone (10 mg/kg) or in combination with zolpidem (10 mg/kg) or trazodone (20 mg/kg), or vehicle, in crossover experiments. Home polysomnography was performed in 12 healthy male volunteers in a randomised, placebo-controlled, 4-week crossover study. Subjects received placebo, caffeine (150 mg) or caffeine in combination with zolpidem (10 mg) or trazodone (100 mg). Subjective sleep effects in volunteers were assessed using the Leeds Sleep Evaluation Questionnaire.
Results
Caffeine caused a significant prolongation in objective SOL in rats and humans. This effect was sensitive to zolpidem and trazodone, both of which attenuated the caffeine-induced increase in SOL. Furthermore, both hypnotics restored the disruption in subjective measures of sleep onset caused by caffeine in volunteers.
Conclusions
This model therefore provides a promising paradigm in which we can study novel treatments for sleep disorders and an opportunity for direct comparison of results between rodents and humans.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alford CA, Bhatti J, Leigh T, Jamieson AO, Hindmarch I (1996) Caffeine-induced sleep disruption: effects on waking the following day and its reversal with an hypnotic. Hum Psychopharmacol Clin Exp 11:185–198
Bonnet MH, Arand DL (1992) Caffeine use as a model of acute and chronic insomnia. Sleep 15:526–536
Brunner DP, Dijk DJ, Munch M, Borbely AA (1991) Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology (Berl) 104(1):1–5
Caccia S, Ballabio M, Fanelli R, Guiso G, Zanini MG (1981) Determination of plasma and brain concentrations of trazodone and its metabolite, 1-m-chlorophenylpiperazine, by gas–liquid chromatography. J Chromatogr 210:311–318
Cluydts R, De Roeck J, Cosyns P, Lacante P (1995) Antagonizing the effects of experimentally induced sleep disturbance in healthy volunteers by lormetazepam and zolpidem. J Clin Psychopharmacol 15:132–137
Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G (1986) Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 237:649–658
Drover D, Lemmens H, Naidu S, Cevallos W, Darwish M, Stanski D (2000) Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem. Clin Ther 22:1443–1461
Garrigou-Gadenne D, Burke JT, Durand A, Depoortere H, Thenot JP, Morselli PL (1989) Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat. J Pharmacol Exp Ther 248:1283–1288
Georgotas A, Forsell TL, Mann JJ, Kim M, Gershon S (1982) Trazodone hydrochloride: a wide spectrum antidepressant with a unique pharmacological profile. A review of its neurochemical effects, pharmacology, clinical efficacy, and toxicology. Pharmacotherapy 2:255–265
Gottesmann C, Gandolfo G, Arnaud C, Gauthier P (1998) The intermediate stage and paradoxical sleep in the rat: influence of three generations of hypnotics. Eur J Neurosci 10:409–414
Haffmans PM, Vos MS (1999) The effects of trazodone on sleep disturbances induced by brofaromine. Eur Psychiatry 14:167
Haller CA, Jacob P 3rd, Benowitz NL (2004) Enhanced stimulant and metabolic effects of combined ephedrine and caffeine. Clin Pharmacol Ther 75:259–273
Hindmarch I, Harrison C (1988) The effects of paroxetine and other antidepressants in combination with alcohol in psychomotor activity related to car driving. Hum Psychopharmacol Clin Exp 3:13–20
Hindmarch I, Rigney U, Stanley N, Quinlan P, Rycroft J, Lane J (2000) A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology (Berl) 149:203–216
Iber C, Redline S, Kaplan Gilpin AM, Quan SF, Zhang L, Gottlieb DJ, Rapoport D, Resnick HE, Sanders M, Smith P (2004) Polysomnography performed in the unattended home versus the attended laboratory setting—Sleep Heart Health Study methodology. Sleep 27:536–540
Ivarsson M, Paterson LM, Hutson PH (2005) Antidepressants and REM sleep in Wistar–Kyoto and Sprague–Dawley rats. Eur J Pharmacol 522(1–3):63–71
Kantor S, Jakus R, Bodizs R, Halasz P, Bagdy G (2002) Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light–dark phase shift. Brain Res 943:105–111
Karacan I, Thornby JI, Anch MA, Booth GH, Williams MD, Salis PJ (1976) Dose-related sleep disturbances induced by coffee and caffeine. Clin Pharmacol Ther 20(6):682–689
Lancel M (1999) Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists. Sleep 22:33–42
Lelkes Z, Obal F Jr, Alfoldi P, Erdos A, Rubicsek G, Benedek G (1994) Effects of acute and chronic treatment with trazodone, an antidepressant, on the sleep–wake activity in rats. Pharmacol Res 30:105–115
Mendelson WB (2005) A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry 66:469–476
Montgomery I, Oswald I, Morgan K, Adam K (1983) Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol 16:139–144
Montplaisir J, Hawa R, Moller H, Morin C, Fortin M, Matte J, Reinish L, Shapiro CM (2003) Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement. Hum Psychopharmacol 18:29–38
National Sleep Disorders Research Plan (2003) http://www.nhlbi.nih.gov/health/prof/sleep/res_plan/index.html
Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF 3rd, Kupfer DJ (1997) Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 278:2170–2177
Okuma T, Matsuoka H, Matsue Y, Toyomura K (1982) Model insomnia by methylphenidate and caffeine and use in the evaluation of temazepam. Psychopharmacology (Berl) 76:201–208
Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283:1305–1322
Parrott AC, Hindmarch I (1978) Factor analysis of a sleep evaluation questionnaire. Psychol Med 8:325–329
Rabat A, Bouyer JJ, Aran JM, Le Moal M, Mayo W (2005) Chronic exposure to an environmental noise permanently disturbs sleep in rats: inter-individual vulnerability. Brain Res 1059:72–82
Rechtschaffen A, Kales A (1968) A manual of standardised terminology: techniques and scoring system for sleep stages of human subjects. National Institutes of Health, Bethesda, Maryland
Schwierin B, Borbely AA, Tobler I (1996) Effects of N6-cyclopentyladenosine and caffeine on sleep regulation in the rat. Eur J Pharmacol 300:163–171
Shinomiya K, Shigemoto Y, Okuma C, Mio M, Kamei C (2003) Effects of short-acting hypnotics on sleep latency in rats placed on grid suspended over water. Eur J Pharmacol 460:139–144
Shinomiya K, Omichi J, Ohnishi R, Ito H, Yoshida T, Kamei C (2004) Effects of chlorogenic acid and its metabolites on the sleep–wakefulness cycle in rats. Eur J Pharmacol 504:185–189
Vogel V, Sanchez C, Jennum P (2002) EEG measurements by means of radiotelemetry after intracerebroventricular (ICV) cannulation in rodents. J Neurosci Methods 118(1):89–96
Walsh JK, Schweitzer PK, Sugerman JL, Muehlbach MJ (1990) Transient insomnia associated with a 3-hour phase advance of sleep time and treatment with zolpidem. J Clin Psychopharmacol 10:184–189
Walsh JK, Erman MK, Erwin CW, Jamieson AO, Mahowald MW, Regestein QR, Scharf MB, Tigel P, Vogel GW, Catesby Ware J (1998) Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia. Hum Psychopharmacol 13:191–198
Wang Y, Lau CE (1998) Caffeine has similar pharmacokinetics and behavioral effects via the i.p. and p.o. routes of administration. Pharmacol Biochem Behav 60:271–278
Wilson SJ, Bailey JE, Alford C, Nutt DJ (2000) Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers. J Psychopharmacol 14:378–386
Yamadera H, Nakamura S, Suzuki H, Endo S (1998) Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects. Psychiatry Clin Neurosci 52:439–443
Acknowledgement
This study was funded by an unrestricted educational grant from Merck Sharp and Dohme.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Paterson, L.M., Wilson, S.J., Nutt, D.J. et al. A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers. Psychopharmacology 191, 943–950 (2007). https://doi.org/10.1007/s00213-006-0672-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-006-0672-0